CME Outfitters Announces Live psychCME TV Activity: "Pharmacotherapy: Roadmap to Recovery from Schizophrenia (Part 1)" Premieres Wednesday, July 19, 2006

CME Outfitters announces an upcoming live and interactive psychCME TV activity titled "Pharmacotherapy: Roadmap to Recovery from Schizophrenia (Part 1)." Offered as a live satellite broadcast, webcast, and telephone audioconference premiering Wednesday, July 19, 2006, from 12:00 p.m.–1:00 p.m. ET, the activity will focus on providing current and clinically relevant data about pharmacotherapy options to help patients with schizophrenia progress toward recovery and live a full and productive life.

Rockville, MD (PRWEB) June 8, 2006 -- CME Outfitters, LLC, nationally accredited provider of multidisciplinary medical education programming and related healthcare communications services, is pleased to announce an upcoming live and interactive evidence-based psychCME TV activity titled "Pharmacotherapy: Roadmap to Recovery from Schizophrenia (Part 1)."

Offered as a live satellite broadcast, webcast, and telephone audioconference premiering Wednesday, July 19, 2006, from 12:00 p.m.–1:00 p.m. ET, the activity will focus on providing current and clinically relevant data about pharmacotherapy options to help patients with schizophrenia progress toward recovery and live a full and productive life. The recorded satellite broadcast will re-air from 3:00 p.m.–4:00 p.m. ET. This CE activity will also be available as an archived webcast, podcast, and telephone audioconference shortly after the live broadcast, and available as a videotape or multimedia CD-ROM in August 2006.

There is no fee for participation in this activity, or to obtain a CE certificate; however, registration is required. Three forms of registration are accepted:

Online: Visit the activity details page at http://www.cmeoutfitters.com/cmea.asp?ID=178

Phone: Call 877.CME.PROS (877.263.7767)

Fax: Visit the activity details page at http://www.cmeoutfitters.com/cmea.asp?ID=178, print and complete the activity details form, and fax to 240.243.1033

Statement of Need:

Schizophrenia can be a severe mental illness characterized by a decline of the patient’s functioning and relationship with the outside world. Schizophrenia has a lifetime prevalence of about 1–1.5%, and care for patients with schizophrenia consumes a larger than expected portion of healthcare costs and social services. Therefore, the potential for recovery is an important element of the treatment course. The recovery movement is often thought of in the rehabilitation setting, psychosocial setting, and advocacy groups and less frequently in terms of medications used to treat chronic disease. However, when discussing patients with schizophrenia, recovery refers to a process or journey to learn "a new way of living a satisfying, hopeful, and contributing life even with the limitations caused by illness." Factors influencing recovery include an initial and early response to a single medication as well as adherence to treatment, which is often compromised by undesirable side effects. In Part 1 of this evidence-based CME Outfitters/psychCME TV activity, clinicians will learn to design more effective courses of schizophrenia treatment that incorporate targeted pharmacotherapy as a key component of the recovery process.

Faculty:

Stephen R. Marder, MD

Professor and Director, Section on Psychosis

Semel Institute for Neuroscience at UCLA

Director, Mental Illness Research, Education, and Clinical Center

David Geffen School of Medicine at UCLA

VA Greater Los Angeles Healthcare System

Los Angeles, CA

        

Peter J. Weiden, MD

Professor of Psychiatry

Director, Schizophrenia Research Service

SUNY Downstate Medical Center

Kings County Hospital Center

Brooklyn, NY

psychCME Moderator:

Prakash S. Masand, MD

Consulting Professor of Psychiatry

Duke University Medical Center

Durham, NC

Learning Objectives:

At the end of this CE activity, participants should be able to:

- Describe the long-term clinical implications of working toward a recovery concept.

- Assess the strengths of the current evidence supporting the efficacy of pharmacotherapy as a component of recovery.

- Utilize clinical judgement to select individualized targeted treatment based on side effects and efficacy.

Target Audience:

Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals with an interest in mental health.

Commercial Support:

CME Outfitters, LLC, gratefully acknowledges an educational grant from Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc., in support of this CE activity.

Credit Information:

CME Credit (Physicians):

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):

This Educational Activity is presented by CME Outfitters, LLC, which has been approved as a provider of continuing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. It has been assigned code 5UYSJZ-PRV-0497. 1.2 contact hours (Pharmacology)

CEP Credit (Psychologists):

CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)

NASW Credit (Social Workers):

This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.

CCMC Credit (Certified Case Managers):

This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):

CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)

Universal Program Number: 376-999-06-013-L01 (live presentation) 376-999-06-013-H01 (recorded programs)

To receive credit, participants must review all activity materials in their entirety, score 70% or above on a post-test, and fully complete and return both the credit request form and activity evaluation. A certificate or statement of credit will be mailed within 4-6 weeks to all who successfully complete these requirements.

About CME Outfitters:

CME Outfitters is a full service healthcare communications agency providing continuing education content development, production, marketing, accreditation, and project management services to the healthcare industry. Among its many collaborative ventures, CME Outfitters has played a primary role in the production, certification, marketing, and logistical support for the popular psychCME series of educational activities. For more information on CME Outfitters, including a complete calendar of its free award-winning educational activities, please visit http://www.cmeoutfitters.com, or call 877.CME.PROS (877.263.7767).

To view all of CME Outfitters' recent press releases, visit http://www.cmeoutfitters.com and click on "CME Outfitters in the News" or visit http://www.prweb.com and search for "CME Outfitters."

CME Outfitters publishes a weekly e-newsletter, which is a convenient way to stay informed of all CME Outfitters news and information. To subscribe, visit http://www.cmeoutfitters.com and click on "Register for Updates."

Contact: Jessica Primanzon

CME Outfitters, LLC

240.243.1308 direct

240.243.1033 fax

###


Contact Information
Jessica Primanzon
CME OUTFITTERS
http://www.cmeoutfitters.com
240.243.1308

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy